カテゴリー： LP Information, 世界, 医療/バイオ

世界のインスリン送達装置市場予測 2023年-2029年

◆英語タイトル：Global Insulin Delivery Systems Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU2868）◆商品コード：LP23JU2868
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のインスリン送達装置市場」は、過去の販売実績から2022年の世界のインスリン送達装置の総販売量を検討し、2023年から2029年の予測されるインスリン送達装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のインスリン送達装置の市場規模を掲載し、XXX百万米ドル規模の世界のインスリン送達装置市場の詳細な分析を提供します。本インサイトレポートは、世界のインスリン送達装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のインスリン送達装置市場における各社の独自のポジションをより深く理解するために、インスリン送達装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のインスリン送達装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。インスリン送達装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。インスリン送達装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。インスリン送達装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

インスリン送達装置の世界主要メーカーとしては、Becton, Dickinson and Company、 Novo Nordisk、 Medtronic、 Sanofi、 ELI Lilly and Company、 Ypsomed Holding、 Animas Corporation、 Tandem Diabetes Care、 Insulet Corporation、 Bioconなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のインスリン送達装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではインスリン送達装置市場をセグメンテーションし、種類別 (インスリンペン、インスリンポンプ、インスリン注射器)、用途別 (在宅医療、病院・診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：インスリンペン、インスリンポンプ、インスリン注射器

・用途別区分：在宅医療、病院・診療所

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のインスリン送達装置市場の10年間の市場状況・展望は？
・世界および地域別に見たインスリン送達装置市場成長の要因は何か？
・インスリン送達装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・インスリン送達装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：インスリン送達装置の年間販売量2018-2029、地域別現状・将来分析
・インスリン送達装置の種類別セグメント：インスリンペン、インスリンポンプ、インスリン注射器
・インスリン送達装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・インスリン送達装置の用途別セグメント：在宅医療、病院・診療所
・インスリン送達装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のインスリン送達装置市場
・企業別のグローバルインスリン送達装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別のインスリン送達装置の年間売上：2018-2023年の売上、市場シェア
・企業別のインスリン送達装置販売価格
・主要企業のインスリン送達装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

インスリン送達装置の地域別レビュー
・地域別のインスリン送達装置市場規模2018-2023：年間販売量、売上
・主要国別のインスリン送達装置市場規模2018-2023：年間販売量、売上
・南北アメリカのインスリン送達装置販売の成長
・アジア太平洋のインスリン送達装置販売の成長
・ヨーロッパのインスリン送達装置販売の成長
・中東・アフリカのインスリン送達装置販売の成長

南北アメリカ市場
・南北アメリカの国別のインスリン送達装置販売量、売上（2018-2023）
・南北アメリカのインスリン送達装置の種類別販売量
・南北アメリカのインスリン送達装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のインスリン送達装置販売量、売上（2018-2023）
・アジア太平洋のインスリン送達装置の種類別販売量
・アジア太平洋のインスリン送達装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のインスリン送達装置販売量、売上（2018-2023）
・ヨーロッパのインスリン送達装置の種類別販売量
・ヨーロッパのインスリン送達装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のインスリン送達装置販売量、売上（2018-2023）
・中東・アフリカのインスリン送達装置の種類別販売量
・中東・アフリカのインスリン送達装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・インスリン送達装置の製造コスト構造分析
・インスリン送達装置の製造プロセス分析
・インスリン送達装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・インスリン送達装置の主要なグローバル販売業者
・インスリン送達装置の主要なグローバル顧客

地域別のインスリン送達装置市場予測レビュー
・地域別のインスリン送達装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・インスリン送達装置の種類別市場規模予測
・インスリン送達装置の用途別市場規模予測

主要企業分析
Becton, Dickinson and Company、 Novo Nordisk、 Medtronic、 Sanofi、 ELI Lilly and Company、 Ypsomed Holding、 Animas Corporation、 Tandem Diabetes Care、 Insulet Corporation、 Biocon
・企業情報
・インスリン送達装置製品
・インスリン送達装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
LPI (LP Information)’ newest research report, the “Insulin Delivery Systems Industry Forecast” looks at past sales and reviews total world Insulin Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Insulin Delivery Systems sales for 2023 through 2029. With Insulin Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Insulin Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insulin Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin Delivery Systems.
The global Insulin Delivery Systems market size is projected to grow from US$ 13680 million in 2022 to US$ 19000 million in 2029; it is expected to grow at a CAGR of 19000 from 2023 to 2029.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Delivery Systems market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Insulin Pens
Insulin Pumps
Insulin Syringes
Segmentation by application
Homecare
Hospitals & Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insulin Delivery Systems market?
What factors are driving Insulin Delivery Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insulin Delivery Systems market opportunities vary by end market size?
How does Insulin Delivery Systems break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Delivery Systems Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Insulin Delivery Systems by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Insulin Delivery Systems by Country/Region, 2018, 2022 & 2029
2.2 Insulin Delivery Systems Segment by Type
2.2.1 Insulin Pens
2.2.2 Insulin Pumps
2.2.3 Insulin Syringes
2.3 Insulin Delivery Systems Sales by Type
2.3.1 Global Insulin Delivery Systems Sales Market Share by Type (2018-2023)
2.3.2 Global Insulin Delivery Systems Revenue and Market Share by Type (2018-2023)
2.3.3 Global Insulin Delivery Systems Sale Price by Type (2018-2023)
2.4 Insulin Delivery Systems Segment by Application
2.4.1 Homecare
2.4.2 Hospitals & Clinics
2.5 Insulin Delivery Systems Sales by Application
2.5.1 Global Insulin Delivery Systems Sale Market Share by Application (2018-2023)
2.5.2 Global Insulin Delivery Systems Revenue and Market Share by Application (2018-2023)
2.5.3 Global Insulin Delivery Systems Sale Price by Application (2018-2023)
3 Global Insulin Delivery Systems by Company
3.1 Global Insulin Delivery Systems Breakdown Data by Company
3.1.1 Global Insulin Delivery Systems Annual Sales by Company (2018-2023)
3.1.2 Global Insulin Delivery Systems Sales Market Share by Company (2018-2023)
3.2 Global Insulin Delivery Systems Annual Revenue by Company (2018-2023)
3.2.1 Global Insulin Delivery Systems Revenue by Company (2018-2023)
3.2.2 Global Insulin Delivery Systems Revenue Market Share by Company (2018-2023)
3.3 Global Insulin Delivery Systems Sale Price by Company
3.4 Key Manufacturers Insulin Delivery Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Delivery Systems Product Location Distribution
3.4.2 Players Insulin Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin Delivery Systems by Geographic Region
4.1 World Historic Insulin Delivery Systems Market Size by Geographic Region (2018-2023)
4.1.1 Global Insulin Delivery Systems Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Insulin Delivery Systems Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Insulin Delivery Systems Market Size by Country/Region (2018-2023)
4.2.1 Global Insulin Delivery Systems Annual Sales by Country/Region (2018-2023)
4.2.2 Global Insulin Delivery Systems Annual Revenue by Country/Region (2018-2023)
4.3 Americas Insulin Delivery Systems Sales Growth
4.4 APAC Insulin Delivery Systems Sales Growth
4.5 Europe Insulin Delivery Systems Sales Growth
4.6 Middle East & Africa Insulin Delivery Systems Sales Growth
5 Americas
5.1 Americas Insulin Delivery Systems Sales by Country
5.1.1 Americas Insulin Delivery Systems Sales by Country (2018-2023)
5.1.2 Americas Insulin Delivery Systems Revenue by Country (2018-2023)
5.2 Americas Insulin Delivery Systems Sales by Type
5.3 Americas Insulin Delivery Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Delivery Systems Sales by Region
6.1.1 APAC Insulin Delivery Systems Sales by Region (2018-2023)
6.1.2 APAC Insulin Delivery Systems Revenue by Region (2018-2023)
6.2 APAC Insulin Delivery Systems Sales by Type
6.3 APAC Insulin Delivery Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin Delivery Systems by Country
7.1.1 Europe Insulin Delivery Systems Sales by Country (2018-2023)
7.1.2 Europe Insulin Delivery Systems Revenue by Country (2018-2023)
7.2 Europe Insulin Delivery Systems Sales by Type
7.3 Europe Insulin Delivery Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Delivery Systems by Country
8.1.1 Middle East & Africa Insulin Delivery Systems Sales by Country (2018-2023)
8.1.2 Middle East & Africa Insulin Delivery Systems Revenue by Country (2018-2023)
8.2 Middle East & Africa Insulin Delivery Systems Sales by Type
8.3 Middle East & Africa Insulin Delivery Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Delivery Systems
10.3 Manufacturing Process Analysis of Insulin Delivery Systems
10.4 Industry Chain Structure of Insulin Delivery Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Delivery Systems Distributors
11.3 Insulin Delivery Systems Customer
12 World Forecast Review for Insulin Delivery Systems by Geographic Region
12.1 Global Insulin Delivery Systems Market Size Forecast by Region
12.1.1 Global Insulin Delivery Systems Forecast by Region (2024-2029)
12.1.2 Global Insulin Delivery Systems Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Delivery Systems Forecast by Type
12.7 Global Insulin Delivery Systems Forecast by Application
13 Key Players Analysis
13.1 Becton, Dickinson and Company
13.1.1 Becton, Dickinson and Company Company Information
13.1.2 Becton, Dickinson and Company Insulin Delivery Systems Product Portfolios and Specifications
13.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Becton, Dickinson and Company Main Business Overview
13.1.5 Becton, Dickinson and Company Latest Developments
13.2 Novo Nordisk
13.2.1 Novo Nordisk Company Information
13.2.2 Novo Nordisk Insulin Delivery Systems Product Portfolios and Specifications
13.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novo Nordisk Main Business Overview
13.2.5 Novo Nordisk Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Insulin Delivery Systems Product Portfolios and Specifications
13.3.3 Medtronic Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Insulin Delivery Systems Product Portfolios and Specifications
13.4.3 Sanofi Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 ELI Lilly and Company
13.5.1 ELI Lilly and Company Company Information
13.5.2 ELI Lilly and Company Insulin Delivery Systems Product Portfolios and Specifications
13.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ELI Lilly and Company Main Business Overview
13.5.5 ELI Lilly and Company Latest Developments
13.6 Ypsomed Holding
13.6.1 Ypsomed Holding Company Information
13.6.2 Ypsomed Holding Insulin Delivery Systems Product Portfolios and Specifications
13.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ypsomed Holding Main Business Overview
13.6.5 Ypsomed Holding Latest Developments
13.7 Animas Corporation
13.7.1 Animas Corporation Company Information
13.7.2 Animas Corporation Insulin Delivery Systems Product Portfolios and Specifications
13.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Animas Corporation Main Business Overview
13.7.5 Animas Corporation Latest Developments
13.8 Tandem Diabetes Care
13.8.1 Tandem Diabetes Care Company Information
13.8.2 Tandem Diabetes Care Insulin Delivery Systems Product Portfolios and Specifications
13.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Tandem Diabetes Care Main Business Overview
13.8.5 Tandem Diabetes Care Latest Developments
13.9 Insulet Corporation
13.9.1 Insulet Corporation Company Information
13.9.2 Insulet Corporation Insulin Delivery Systems Product Portfolios and Specifications
13.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Insulet Corporation Main Business Overview
13.9.5 Insulet Corporation Latest Developments
13.10 Biocon
13.10.1 Biocon Company Information
13.10.2 Biocon Insulin Delivery Systems Product Portfolios and Specifications
13.10.3 Biocon Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Biocon Main Business Overview
13.10.5 Biocon Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Insulin Delivery Systems Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Insulin Delivery Systems Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Insulin Pens
Table 4. Major Players of Insulin Pumps
Table 5. Major Players of Insulin Syringes
Table 6. Global Insulin Delivery Systems Sales by Type (2018-2023) & (K Units)
Table 7. Global Insulin Delivery Systems Sales Market Share by Type (2018-2023)
Table 8. Global Insulin Delivery Systems Revenue by Type (2018-2023) & ($ million)
Table 9. Global Insulin Delivery Systems Revenue Market Share by Type (2018-2023)
Table 10. Global Insulin Delivery Systems Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Insulin Delivery Systems Sales by Application (2018-2023) & (K Units)
Table 12. Global Insulin Delivery Systems Sales Market Share by Application (2018-2023)
Table 13. Global Insulin Delivery Systems Revenue by Application (2018-2023)
Table 14. Global Insulin Delivery Systems Revenue Market Share by Application (2018-2023)
Table 15. Global Insulin Delivery Systems Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Insulin Delivery Systems Sales by Company (2018-2023) & (K Units)
Table 17. Global Insulin Delivery Systems Sales Market Share by Company (2018-2023)
Table 18. Global Insulin Delivery Systems Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Insulin Delivery Systems Revenue Market Share by Company (2018-2023)
Table 20. Global Insulin Delivery Systems Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Insulin Delivery Systems Producing Area Distribution and Sales Area
Table 22. Players Insulin Delivery Systems Products Offered
Table 23. Insulin Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Insulin Delivery Systems Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Insulin Delivery Systems Sales Market Share Geographic Region (2018-2023)
Table 28. Global Insulin Delivery Systems Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Insulin Delivery Systems Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Insulin Delivery Systems Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Insulin Delivery Systems Sales Market Share by Country/Region (2018-2023)
Table 32. Global Insulin Delivery Systems Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Insulin Delivery Systems Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Insulin Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 35. Americas Insulin Delivery Systems Sales Market Share by Country (2018-2023)
Table 36. Americas Insulin Delivery Systems Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Insulin Delivery Systems Revenue Market Share by Country (2018-2023)
Table 38. Americas Insulin Delivery Systems Sales by Type (2018-2023) & (K Units)
Table 39. Americas Insulin Delivery Systems Sales by Application (2018-2023) & (K Units)
Table 40. APAC Insulin Delivery Systems Sales by Region (2018-2023) & (K Units)
Table 41. APAC Insulin Delivery Systems Sales Market Share by Region (2018-2023)
Table 42. APAC Insulin Delivery Systems Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Insulin Delivery Systems Revenue Market Share by Region (2018-2023)
Table 44. APAC Insulin Delivery Systems Sales by Type (2018-2023) & (K Units)
Table 45. APAC Insulin Delivery Systems Sales by Application (2018-2023) & (K Units)
Table 46. Europe Insulin Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 47. Europe Insulin Delivery Systems Sales Market Share by Country (2018-2023)
Table 48. Europe Insulin Delivery Systems Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Insulin Delivery Systems Revenue Market Share by Country (2018-2023)
Table 50. Europe Insulin Delivery Systems Sales by Type (2018-2023) & (K Units)
Table 51. Europe Insulin Delivery Systems Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Insulin Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Insulin Delivery Systems Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Insulin Delivery Systems Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Insulin Delivery Systems Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Insulin Delivery Systems Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Insulin Delivery Systems Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Insulin Delivery Systems
Table 59. Key Market Challenges & Risks of Insulin Delivery Systems
Table 60. Key Industry Trends of Insulin Delivery Systems
Table 61. Insulin Delivery Systems Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Insulin Delivery Systems Distributors List
Table 64. Insulin Delivery Systems Customer List
Table 65. Global Insulin Delivery Systems Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Insulin Delivery Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Insulin Delivery Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Insulin Delivery Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Insulin Delivery Systems Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Insulin Delivery Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Insulin Delivery Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Insulin Delivery Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Insulin Delivery Systems Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Insulin Delivery Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Insulin Delivery Systems Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Insulin Delivery Systems Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Insulin Delivery Systems Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Insulin Delivery Systems Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Becton, Dickinson and Company Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 80. Becton, Dickinson and Company Insulin Delivery Systems Product Portfolios and Specifications
Table 81. Becton, Dickinson and Company Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Becton, Dickinson and Company Main Business
Table 83. Becton, Dickinson and Company Latest Developments
Table 84. Novo Nordisk Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 85. Novo Nordisk Insulin Delivery Systems Product Portfolios and Specifications
Table 86. Novo Nordisk Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Novo Nordisk Main Business
Table 88. Novo Nordisk Latest Developments
Table 89. Medtronic Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Insulin Delivery Systems Product Portfolios and Specifications
Table 91. Medtronic Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Sanofi Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofi Insulin Delivery Systems Product Portfolios and Specifications
Table 96. Sanofi Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Sanofi Main Business
Table 98. Sanofi Latest Developments
Table 99. ELI Lilly and Company Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. ELI Lilly and Company Insulin Delivery Systems Product Portfolios and Specifications
Table 101. ELI Lilly and Company Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. ELI Lilly and Company Main Business
Table 103. ELI Lilly and Company Latest Developments
Table 104. Ypsomed Holding Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 105. Ypsomed Holding Insulin Delivery Systems Product Portfolios and Specifications
Table 106. Ypsomed Holding Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Ypsomed Holding Main Business
Table 108. Ypsomed Holding Latest Developments
Table 109. Animas Corporation Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 110. Animas Corporation Insulin Delivery Systems Product Portfolios and Specifications
Table 111. Animas Corporation Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Animas Corporation Main Business
Table 113. Animas Corporation Latest Developments
Table 114. Tandem Diabetes Care Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 115. Tandem Diabetes Care Insulin Delivery Systems Product Portfolios and Specifications
Table 116. Tandem Diabetes Care Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Tandem Diabetes Care Main Business
Table 118. Tandem Diabetes Care Latest Developments
Table 119. Insulet Corporation Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 120. Insulet Corporation Insulin Delivery Systems Product Portfolios and Specifications
Table 121. Insulet Corporation Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Insulet Corporation Main Business
Table 123. Insulet Corporation Latest Developments
Table 124. Biocon Basic Information, Insulin Delivery Systems Manufacturing Base, Sales Area and Its Competitors
Table 125. Biocon Insulin Delivery Systems Product Portfolios and Specifications
Table 126. Biocon Insulin Delivery Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Biocon Main Business
Table 128. Biocon Latest Developments
List of Figures
Figure 1. Picture of Insulin Delivery Systems
Figure 2. Insulin Delivery Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Delivery Systems Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Insulin Delivery Systems Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Insulin Delivery Systems Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Insulin Pens
Figure 10. Product Picture of Insulin Pumps
Figure 11. Product Picture of Insulin Syringes
Figure 12. Global Insulin Delivery Systems Sales Market Share by Type in 2022
Figure 13. Global Insulin Delivery Systems Revenue Market Share by Type (2018-2023)
Figure 14. Insulin Delivery Systems Consumed in Homecare
Figure 15. Global Insulin Delivery Systems Market: Homecare (2018-2023) & (K Units)
Figure 16. Insulin Delivery Systems Consumed in Hospitals & Clinics
Figure 17. Global Insulin Delivery Systems Market: Hospitals & Clinics (2018-2023) & (K Units)
Figure 18. Global Insulin Delivery Systems Sales Market Share by Application (2022)
Figure 19. Global Insulin Delivery Systems Revenue Market Share by Application in 2022
Figure 20. Insulin Delivery Systems Sales Market by Company in 2022 (K Units)
Figure 21. Global Insulin Delivery Systems Sales Market Share by Company in 2022
Figure 22. Insulin Delivery Systems Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Insulin Delivery Systems Revenue Market Share by Company in 2022
Figure 24. Global Insulin Delivery Systems Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Insulin Delivery Systems Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Insulin Delivery Systems Sales 2018-2023 (K Units)
Figure 27. Americas Insulin Delivery Systems Revenue 2018-2023 ($ Millions)
Figure 28. APAC Insulin Delivery Systems Sales 2018-2023 (K Units)
Figure 29. APAC Insulin Delivery Systems Revenue 2018-2023 ($ Millions)
Figure 30. Europe Insulin Delivery Systems Sales 2018-2023 (K Units)
Figure 31. Europe Insulin Delivery Systems Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Insulin Delivery Systems Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Insulin Delivery Systems Revenue 2018-2023 ($ Millions)
Figure 34. Americas Insulin Delivery Systems Sales Market Share by Country in 2022
Figure 35. Americas Insulin Delivery Systems Revenue Market Share by Country in 2022
Figure 36. Americas Insulin Delivery Systems Sales Market Share by Type (2018-2023)
Figure 37. Americas Insulin Delivery Systems Sales Market Share by Application (2018-2023)
Figure 38. United States Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Insulin Delivery Systems Sales Market Share by Region in 2022
Figure 43. APAC Insulin Delivery Systems Revenue Market Share by Regions in 2022
Figure 44. APAC Insulin Delivery Systems Sales Market Share by Type (2018-2023)
Figure 45. APAC Insulin Delivery Systems Sales Market Share by Application (2018-2023)
Figure 46. China Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Insulin Delivery Systems Sales Market Share by Country in 2022
Figure 54. Europe Insulin Delivery Systems Revenue Market Share by Country in 2022
Figure 55. Europe Insulin Delivery Systems Sales Market Share by Type (2018-2023)
Figure 56. Europe Insulin Delivery Systems Sales Market Share by Application (2018-2023)
Figure 57. Germany Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Insulin Delivery Systems Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Insulin Delivery Systems Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Insulin Delivery Systems Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Insulin Delivery Systems Sales Market Share by Application (2018-2023)
Figure 66. Egypt Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Insulin Delivery Systems Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Insulin Delivery Systems in 2022
Figure 72. Manufacturing Process Analysis of Insulin Delivery Systems
Figure 73. Industry Chain Structure of Insulin Delivery Systems
Figure 74. Channels of Distribution
Figure 75. Global Insulin Delivery Systems Sales Market Forecast by Region (2024-2029)
Figure 76. Global Insulin Delivery Systems Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Insulin Delivery Systems Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Insulin Delivery Systems Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Insulin Delivery Systems Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Insulin Delivery Systems Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のインスリン送達装置市場予測 2023年-2029年(Global Insulin Delivery Systems Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のインスリン投与ペン市場予測 2023年-2029年
  • 使い捨て型インスリン投与装置の世界市場見通し2023年-2029年
  • 使い捨て型インスリン送達ポンプの世界市場見通し2023年-2029年
  • 世界のインスリン投与機器市場(2028年)

    • ◆H&Iグローバルリサーチのお客様（例）◆